SCHEMBL5083226

SCHEMBL5083226

CCc1cc(C(CCN)Oc2cccc3ccccc23)cs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 18/20 0.57
SLC6A4 P31645 18/20 0.57
SLC6A3 Q01959 3/20 0.57
MLNR O43193 1/20 0.43
CACNA1F O60840 1/20 0.43
CYP1A2 P05177 1/20 0.43
ADRB1 P08588 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
GAA P10253 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
DRD2 P14416 1/20 0.43
KCNE1 P15382 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
MC4R P32245 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL3284 0.92 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL3285 0.78 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL28017684 0.78 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL541162 0.78 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3CYP2D6
Bromide SCHEMBL6903611 0.77 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL4971076 0.75 SLC6A4 (0.60) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL5079373 0.74 SLC6A4 (0.56) SLC6A2SLC6A4SLC6A3
(S)-Norduloxetine SCHEMBL4573573 0.73 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
R-Norduloxetine SCHEMBL2634027 0.73 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3MLNRCACNA1F
SCHEMBL2487646 0.72 SLC6A4 (0.64) SLC6A2SLC6A4SLC6A3MLNRCACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed